Evidence method
Level · gp.fundamentals.debt_to_revenue
836.73% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
VRCA · Dec 31, 2023
Verrica Pharmaceuticals Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-022659General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
7.06% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-752.87% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
19.95% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
90.24% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-1283.35% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
396.08% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
280.56% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20240/5 normalizedLevel 3Dec 31, 20240/9 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20252/7 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 1453.58%
- Current
- 836.73%
- Delta
- -616.85%
- Previous
- 2.23%
- Current
- 7.06%
- Delta
- 4.84%
- Previous
- -507.75%
- Current
- -752.87%
- Delta
- -245.12%
- Previous
- 9.56%
- Current
- 19.95%
- Delta
- 10.38%
- Previous
- 89.72%
- Current
- 90.24%
- Delta
- 0.53%
- Previous
- -819.92%
- Current
- -1283.35%
- Delta
- -463.44%
- Previous
- 223.17%
- Current
- 396.08%
- Delta
- 172.90%
- Previous
- 331.26%
- Current
- 280.56%
- Delta
- -50.70%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · VRCA Fundamental State →Has State · Verrica Pharmaceuticals Inc. →Transitioned To · VRCA Fundamental State →Transitioned To · VRCA BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · VRCA CAPEX_INTENSITY_INCREASED →Transitioned To · VRCA CASH_GENERATION_DECREASED →Transitioned To · VRCA INVENTORY_PRESSURE_INCREASED →Transitioned To · VRCA MARGIN_INCREASED →Transitioned To · VRCA PROFITABILITY_DECREASED →Transitioned To · VRCA R_AND_D_INTENSITY_INCREASED →Transitioned To · VRCA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.